{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:28:18Z","timestamp":1792794498651,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["MRG5980145"],"award-info":[{"award-number":["MRG5980145"]}],"id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["NRCT5-RSA63015-12"],"award-info":[{"award-number":["NRCT5-RSA63015-12"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007943","name":"Graduate School, Kasetsart University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","award":["P19-50843"],"award-info":[{"award-number":["P19-50843"]}],"id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","award":["TRG6280009"],"award-info":[{"award-number":["TRG6280009"]}],"id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.yexcr.2021.112765","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T04:48:01Z","timestamp":1628052481000},"page":"112765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Integrin \u03b15 mediates intrinsic cisplatin resistance in three-dimensional nasopharyngeal carcinoma spheroids via the inhibition of phosphorylated ERK \/caspase-3 induced apoptosis"],"prefix":"10.1016","volume":"406","author":[{"given":"Utapin","family":"Ngaokrajang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tavan","family":"Janvilisri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-0161","authenticated-orcid":false,"given":"Udom","family":"Sae-Ueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apisara","family":"Prungsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-9261","authenticated-orcid":false,"given":"Pichamon","family":"Kiatwuthinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.112765_bib1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2021.112765_bib2","series-title":"Global Trends in Incidence and Mortality of Nasopharyngeal Carcinoma","author":"Tang","year":"2016"},{"key":"10.1016\/j.yexcr.2021.112765_bib3","article-title":"Nasopharyngeal cancer in the world: epidemiology, incidence mortality and risk factors","volume":"5","author":"Salehiniya","year":"2018","journal-title":"WCRJ 2018"},{"key":"10.1016\/j.yexcr.2021.112765_bib4","first-page":"2441","article-title":"Epstein-barr virus mediated signaling in nasopharyngeal carcinoma","volume":"12","author":"Richardo","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2021.112765_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jnci\/djz044","article-title":"Current treatment landscape of nasopharyngeal carcinoma and potential trials evaluating the value of immunotherapy, JNCI","volume":"111","author":"Le","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yexcr.2021.112765_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12885-019-5688-z","article-title":"Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Canc."},{"key":"10.1016\/j.yexcr.2021.112765_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/cancers10120495","article-title":"Mechanisms of matrix-induced chemoresistance of breast cancer cells-deciphering novel potential targets for a cell sensitization","volume":"10","author":"Jakubzig","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2021.112765_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038737","article-title":"alphaV integrin induces multicellular radioresistance in human nasopharyngeal carcinoma via activating SAPK\/JNK pathway","volume":"7","author":"Ou","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112765_bib9","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Damiano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2021.112765_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms131215588","article-title":"Elevated levels of lewis Y and integrin \u03b15\u03b21 correlate with chemotherapeutic drug resistance in epithelial ovarian carcinoma","volume":"13","author":"Hu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2021.112765_bib11","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1038\/sj.onc.1204554","article-title":"Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells","volume":"20","author":"Aoudjit","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2021.112765_bib12","first-page":"1207","article-title":"Involvement of oligosaccharide changes in \u03b15\u03b21 integrin in a cisplatin-resistant human squamous cell carcinoma cell line","volume":"2","author":"Nakahara","year":"2003","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.yexcr.2021.112765_bib13","first-page":"7219","article-title":"\u03b21-Integrin","volume":"17","author":"Barkan","year":"2011","journal-title":"A Potential Therapeutic Target in the Battle against Cancer Recurrence"},{"key":"10.1016\/j.yexcr.2021.112765_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/cancers5010027","article-title":"Integrin \u03b15\u03b21, the fibronectin receptor, as a pertinent therapeutic target in solid tumors","volume":"5","author":"Schaffner","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2021.112765_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1091\/mbc.6.6.725","article-title":"Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin","volume":"6","author":"Varner","year":"1995","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2021.112765_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568009023334033","article-title":"Integrins as novel drug targets for overcoming innate drug resistance","volume":"2","author":"Damiano","year":"2002","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.yexcr.2021.112765_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","article-title":"Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance","volume":"25","author":"Seguin","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112765_bib18","first-page":"96","article-title":"Significance of integrin \u03b15 gene expression as a prognostic factor in node-negative non-small cell lung cancer","volume":"6","author":"Adachi","year":"2000"},{"key":"10.1016\/j.yexcr.2021.112765_bib19","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-09-2319","article-title":"Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin","volume":"70","author":"Nam","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2021.112765_bib20","first-page":"2697","article-title":"Integrin \u03b15 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker","volume":"13","author":"Lu","year":"2019"},{"key":"10.1016\/j.yexcr.2021.112765_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2019.02.012","article-title":"miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1","volume":"378","author":"Huang","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2021.112765_bib22","first-page":"158","article-title":"Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines","volume":"21","author":"Song","year":"2002","journal-title":"Chin. J. Canc."},{"key":"10.1016\/j.yexcr.2021.112765_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73498-y","article-title":"Lectin affinity chromatography and quantitative proteomic analysis reveal that galectin-3 is associated with metastasis in nasopharyngeal carcinoma","volume":"10","author":"Aimjongjun","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112765_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.yexcr.2021.112765_bib25","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2021.112765_bib26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nnano.2007.388","article-title":"Nanomechanical analysis of cells from cancer patients","volume":"2","author":"Cross","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.yexcr.2021.112765_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12668-016-0191-3","article-title":"Discrimination between normal and cancerous cells using AFM","volume":"6","author":"Lekka","year":"2016","journal-title":"BioNanoScience"},{"key":"10.1016\/j.yexcr.2021.112765_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0006-3495(00)76614-8","article-title":"Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: an atomic force microscopy study","volume":"78","author":"Rotsch","year":"2000","journal-title":"Biophys. J."},{"key":"10.1016\/j.yexcr.2021.112765_bib29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.bbagen.2016.06.010","article-title":"Cell stiffness determined by atomic force microscopy and its correlation with cell motility","volume":"1860","author":"Luo","year":"2016","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.yexcr.2021.112765_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmbbm.2015.04.030","article-title":"Stiffness of cancer cells measured with an AFM indentation method","volume":"49","author":"Hayashi","year":"2015","journal-title":"Journal of the Mechanical Behavior of Biomedical Materials"},{"key":"10.1016\/j.yexcr.2021.112765_bib31","first-page":"203","article-title":"Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT\u2013mTOR\u2013S6K signaling and drug responses","volume":"130","author":"Riedl","year":"2017","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2021.112765_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.semcancer.2005.05.002","article-title":"Three-dimensional tissue culture models in cancer biology, Semin","volume":"15","author":"Kim","year":"2005","journal-title":"Cancer Biol"},{"key":"10.1016\/j.yexcr.2021.112765_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bit.26845","article-title":"3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs","volume":"116","author":"Nunes","year":"2019","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.yexcr.2021.112765_bib34","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3892\/ol.2017.5697","article-title":"Modeling nasopharyngeal carcinoma in three dimensions","volume":"13","author":"Siva Sankar","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.yexcr.2021.112765_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.matbio.2008.02.008","article-title":"Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells","volume":"27","author":"Serebriiskii","year":"2008","journal-title":"Matrix Biol."},{"key":"10.1016\/j.yexcr.2021.112765_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.21315\/tlsr2016.27.3.17","article-title":"Establishment and analysis of the 3-dimensional (3D) spheroids generated from the nasopharyngeal carcinoma cell line HK1","volume":"27","author":"Muniandy","year":"2016","journal-title":"Trop. Life Sci. Res."},{"key":"10.1016\/j.yexcr.2021.112765_bib37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrm2236","article-title":"The third dimension bridges the gap between cell culture and live tissue","volume":"8","author":"Pampaloni","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112765_bib38","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-018-06889-5","article-title":"Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma","volume":"9","author":"Lin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2021.112765_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1007034012642","article-title":"Over expression of integrin \u03b1 5 \u03b2 1 in human hepatocellular carcinoma cell line suppresses cell proliferation in vitro and tumorigenicity in nude mice","volume":"207","author":"Zhou","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yexcr.2021.112765_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-13-73","article-title":"Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D","volume":"13","author":"Laurent","year":"2013","journal-title":"BMC Canc."},{"key":"10.1016\/j.yexcr.2021.112765_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1476-4598-10-84","article-title":"Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb\/E2F pathways to affect breast cancer metastasis","volume":"10","author":"Wang","year":"2011","journal-title":"Mol. Canc."},{"key":"10.1016\/j.yexcr.2021.112765_bib42","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.yexcr.2012.03.026","article-title":"Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system","volume":"318","author":"Karlsson","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2021.112765_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1013156407224","article-title":"Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies","volume":"20","author":"Hazlehurst","year":"2001","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.yexcr.2021.112765_bib44","first-page":"337","article-title":"Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2\/DDP and screening of drug-resistant genes","volume":"22","author":"Jiang","year":"2003","journal-title":"Ai zheng Aizheng Chinese journal of cancer"},{"key":"10.1016\/j.yexcr.2021.112765_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1248\/bpb.b14-00604","article-title":"Nano-mechanical reinforcement in drug-resistant ovarian cancer cells","volume":"38","author":"Seo","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.yexcr.2021.112765_bib46","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1039\/C3IB40246K","article-title":"The role of Rho GTPase in cell stiffness and cisplatin resistance in ovarian cancer cells","volume":"6","author":"Sharma","year":"2014","journal-title":"Integrative Biology"},{"key":"10.1016\/j.yexcr.2021.112765_bib47","first-page":"462","article-title":"Actin remodeling confers BRAF inhibitor resistance to melanoma cells through","volume":"35","author":"Kim","year":"2016","journal-title":"YAP\/TAZ activation"},{"key":"10.1016\/j.yexcr.2021.112765_bib48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.nano.2011.09.015","article-title":"Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells","volume":"8","author":"Sharma","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.yexcr.2021.112765_bib49","first-page":"369","volume":"124","author":"Mierke","year":"2011","journal-title":"Integrin \u03b15\u03b21 facilitates cancer cell invasion through enhanced contractile forces"},{"key":"10.1016\/j.yexcr.2021.112765_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12885-017-3953-6","article-title":"Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins","volume":"18","author":"Lovitt","year":"2018","journal-title":"BMC Canc."},{"key":"10.1016\/j.yexcr.2021.112765_bib51","doi-asserted-by":"crossref","first-page":"33376","DOI":"10.1038\/srep33376","article-title":"Integrin \u03b16\/Akt\/Erk signaling is essential for human breast cancer resistance to radiotherapy","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112765_bib52","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/9511","article-title":"Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo","volume":"5","author":"Sethi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2021.112765_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/738137","article-title":"Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation","volume":"2011","author":"Vachon","year":"2011","journal-title":"J Signal Transduct"},{"key":"10.1016\/j.yexcr.2021.112765_bib54","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1073\/pnas.1202120109","article-title":"Governing epidermal homeostasis by coupling cell\u2013cell adhesion to integrin and growth factor signaling, proliferation, and apoptosis","volume":"109","author":"Livshits","year":"2012","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.yexcr.2021.112765_bib55","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1158\/1078-0432.CCR-06-2891","article-title":"Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma","volume":"13","author":"Cillessen","year":"2007","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.yexcr.2021.112765_bib56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.emboj.7600544","article-title":"XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs","volume":"24","author":"Scott","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2021.112765_bib57","doi-asserted-by":"crossref","first-page":"27058","DOI":"10.1074\/jbc.M102415200","article-title":"X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes","volume":"276","author":"Suzuki","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112765_bib58","doi-asserted-by":"crossref","first-page":"39435","DOI":"10.1074\/jbc.M004583200","article-title":"Requirement for ERK activation in cisplatin-induced apoptosis","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112765_bib59","first-page":"269","volume":"136","author":"Hazlehurst","year":"2007","journal-title":"\u03b21 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells"},{"key":"10.1016\/j.yexcr.2021.112765_bib60","first-page":"647","article-title":"Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK, nat","volume":"5","author":"Allan","year":"2003","journal-title":"Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112765_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.canlet.2012.10.004","article-title":"The \u03b26-integrin-ERK\/MAP kinase pathway contributes to chemo resistance in colon cancer","volume":"328","author":"Liu","year":"2013","journal-title":"Canc. Lett."},{"key":"10.1016\/j.yexcr.2021.112765_bib62","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41598-018-37443-4","article-title":"Crabp2 promotes metastasis of lung cancer cells via HuR and integrin \u03b21\/FAK\/ERK signaling","volume":"9","author":"Wu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112765_bib63","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/sj.bjc.6603171","article-title":"Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours","volume":"94","author":"Cianfrocca","year":"2006","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.yexcr.2021.112765_bib64","doi-asserted-by":"crossref","first-page":"E964","DOI":"10.1152\/ajpendo.00239.2003","article-title":"Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation","volume":"285","author":"Faridi","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:26:55Z","timestamp":1778646415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0014482721003189"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112765","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrin \u03b15 mediates intrinsic cisplatin resistance in three-dimensional nasopharyngeal carcinoma spheroids via the inhibition of phosphorylated ERK \/caspase-3 induced apoptosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112765"}}